narcolepsy type 1 cataplexy
Selected indexed studies
- Oveporexton, an Oral Orexin Receptor 2-Selective Agonist, in Narcolepsy Type 1. (N Engl J Med, 2025) [PMID:40367374]
- Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1. (N Engl J Med, 2023) [PMID:37494485]
- Treatment of Narcolepsy Type 1 With Orexin: A Systematic Review. (Cureus, 2024) [PMID:39898129]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Oveporexton, an Oral Orexin Receptor 2-Selective Agonist, in Narcolepsy Type 1. (2025) pubmed
- Narcolepsy and Idiopathic Hypersomnia. (2023) pubmed
- REM sleep in narcolepsy. (2024) pubmed
- Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1. (2023) pubmed
- Treatment of Narcolepsy Type 1 With Orexin: A Systematic Review. (2024) pubmed
- Narcolepsy. (2022) pubmed
- Type 1 narcolepsy without cataplexy and treatment progress: a case report. (2021) pubmed
- Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment. (2019) pubmed
- Narcolepsies, update in 2023. (2023) pubmed
- Tetrad of Narcolepsy Type 1: Treatment and Management. (2024) pubmed